Success Metrics

Clinical Success Rate
90.0%

Based on 18 completed trials

Completion Rate
90%(18/20)
Active Trials
1(3%)
Results Posted
28%(5 trials)
Terminated
2(7%)

Phase Distribution

Ph not_applicable
6
21%
Ph phase_2
10
34%
Ph phase_3
2
7%
Ph phase_1
4
14%
Ph phase_4
5
17%

Phase Distribution

4

Early Stage

10

Mid Stage

7

Late Stage

Phase Distribution27 total trials
Phase 1Safety & dosage
4(14.8%)
Phase 2Efficacy & side effects
10(37.0%)
Phase 3Large-scale testing
2(7.4%)
Phase 4Post-market surveillance
5(18.5%)
N/ANon-phased studies
6(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

18 of 21 finished

Non-Completion Rate

14.3%

3 ended early

Currently Active

1

trials recruiting

Total Trials

29

all time

Status Distribution
Active(1)
Completed(18)
Terminated(3)
Other(7)

Detailed Status

Completed18
unknown7
Terminated2
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
29
Active
1
Success Rate
90.0%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (14.8%)
Phase 210 (37.0%)
Phase 32 (7.4%)
Phase 45 (18.5%)
N/A6 (22.2%)

Trials by Status

completed1862%
withdrawn13%
unknown724%
terminated27%
recruiting13%

Recent Activity

Clinical Trials (29)

Showing 20 of 29 trialsScroll for more
NCT05267886Phase 4

CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock

Recruiting
NCT02951130Phase 2

Milrinone in Congenital Diaphragmatic Hernia

Completed
NCT07186062

Clinical Outcomes of Levosimendan Versus Dobutamine Versus Milrinone in Cases With Acute Decompensated Heart Failure With Impaired Renal Function

Completed
NCT02098629Phase 2

Concomitant Milrinone and Esmolol Treatment in Patients with Acute Myocardial Infarction

Completed
NCT06562036Not Applicable

Efficacy of Milrinone With Sildenafil in Persistent Pulmonary Hypertension in Children

Completed
NCT02232399Phase 2

Is Levosimendan Superior to Milrinone Regarding Acute Kidney Injury After Cardiac Surgery for Congenital Heart Disease?

Completed
NCT06077721

Milrinone on Right Ventricular Strain in Cardiac Surgery

Unknown
NCT05122884Phase 2

Milrinone Versus Placebo in Patients With Septic Shock

Unknown
NCT05132153Phase 4

Effect of Nebulized Milrinone on Right Ventricular Hemodynamics in Adult Cardiac Surgery

Unknown
NCT01841177Phase 2

Evaluating Precision of Therapy - Milrinone

Completed
NCT03207165Phase 4

Milrinone Versus Dobutamine in Critically Ill Patients

Completed
NCT04391478Phase 1

Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension

Completed
NCT02712788Phase 2

Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage

Terminated
NCT02726620Not Applicable

Decision Support for Intraoperative Low Blood Pressure

Completed
NCT03855579Phase 4

Levosimendan Versus Milrinone in Off Pump CABG Surgery

Unknown
NCT03823781Phase 3

Prophylactic Use of Milrinone After Congenital Heart Surgery in Infants

Unknown
NCT01956006Phase 1

Pilot Study of Slow Release Oral Milrinone in Patients With Advanced Heart Failure

Completed
NCT02640846Phase 4

Effects of Levosimendan, Milrinone and Norepinephrine on Left and Right Ventricular Function in Septic Shock

Unknown
NCT02644057Phase 2

Dobutamaine Versus Milrinone in Cardiorenal Syndrome

Withdrawn
NCT00543309Phase 2

Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
29